VIII.f
Central airway instability - Tracheomalacia
Causative drugs
5
Corticosteroids, inhaled (ICS)
VIII.f
VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia VIII.j VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.j - Laryngeal disorder-Laryngeal nerve palsy (dysphonia, hoarseness) VIII.x VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.x - Opportunistic large airway infection (bacterial, fungal, viral) VIII.ag VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.ag - Vocal cord candidasis X.h X - Systemic/Distant conditions, syndromes and reactions
X.h - Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) XI.y XI - Miscellaneous
XI.y - Adrenal suppression XI.z XI - Miscellaneous
XI.z - Psychiatric symptoms XI.ag XI - Miscellaneous
XI.ag - Vertebral compression fracture XI.ai XI - Miscellaneous
XI.ai - Cushing syndrome XVII.a XVII - Infections & related conditions
XVII.a - Respiratory tract infection incl. pneumonia XVII.b XVII - Infections & related conditions
XVII.b - Opportunistic pulmonary/systemic infections XVII.c XVII - Infections & related conditions
XVII.c - Aspergillosis, pulmonary (invasive, allergic [ABPA], or mycetoma) XVII.e XVII - Infections & related conditions
XVII.e - Pneumocystis jiroveci pneumonia XVII.g XVII - Infections & related conditions
XVII.g - Tuberculosis (pulmonary, pulmonary, extrapulmonary or disseminated). Reactivation or de novo XVII.h XVII - Infections & related conditions
XVII.h - Nontuberculous pulmonary mycobacterial infection/superinfection XVII.k XVII - Infections & related conditions
XVII.k - Bacterial (incl. Pseudomonas) airway colonization XVII.m XVII - Infections & related conditions
XVII.m - Fungal airway infection XVII.x XVII - Infections & related conditions
XVII.x - Aspergillus airway colonization/infection
VIII.f - Central airway instability - Tracheomalacia VIII.j VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.j - Laryngeal disorder-Laryngeal nerve palsy (dysphonia, hoarseness) VIII.x VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.x - Opportunistic large airway infection (bacterial, fungal, viral) VIII.ag VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.ag - Vocal cord candidasis X.h X - Systemic/Distant conditions, syndromes and reactions
X.h - Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) XI.y XI - Miscellaneous
XI.y - Adrenal suppression XI.z XI - Miscellaneous
XI.z - Psychiatric symptoms XI.ag XI - Miscellaneous
XI.ag - Vertebral compression fracture XI.ai XI - Miscellaneous
XI.ai - Cushing syndrome XVII.a XVII - Infections & related conditions
XVII.a - Respiratory tract infection incl. pneumonia XVII.b XVII - Infections & related conditions
XVII.b - Opportunistic pulmonary/systemic infections XVII.c XVII - Infections & related conditions
XVII.c - Aspergillosis, pulmonary (invasive, allergic [ABPA], or mycetoma) XVII.e XVII - Infections & related conditions
XVII.e - Pneumocystis jiroveci pneumonia XVII.g XVII - Infections & related conditions
XVII.g - Tuberculosis (pulmonary, pulmonary, extrapulmonary or disseminated). Reactivation or de novo XVII.h XVII - Infections & related conditions
XVII.h - Nontuberculous pulmonary mycobacterial infection/superinfection XVII.k XVII - Infections & related conditions
XVII.k - Bacterial (incl. Pseudomonas) airway colonization XVII.m XVII - Infections & related conditions
XVII.m - Fungal airway infection XVII.x XVII - Infections & related conditions
XVII.x - Aspergillus airway colonization/infection
1
Hydrochloric acid fumes
I.ao
I - Interstitial/parenchymal lung disease
I.ao - Pulmonary infiltrates II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury II.f II - Pulmonary edema - Acute lung injury - ARDS
II.f - Hypoxemia, low oxygen saturation (may occur in isolation) IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma IV.q IV - Airway involvement
IV.q - Reactive airway dysfunction syndrome (RADS) VIII.f VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia VIII.g VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.g - Tracheal narrowing - Sabre sheath trachea
I.ao - Pulmonary infiltrates II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury II.f II - Pulmonary edema - Acute lung injury - ARDS
II.f - Hypoxemia, low oxygen saturation (may occur in isolation) IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma IV.q IV - Airway involvement
IV.q - Reactive airway dysfunction syndrome (RADS) VIII.f VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia VIII.g VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.g - Tracheal narrowing - Sabre sheath trachea
1
Lidocaine (lignocaine, xylocaine)
II.a
II - Pulmonary edema - Acute lung injury - ARDS
II.a - Pulmonary edema, noncardiogenic (NCPE) II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury II.g II - Pulmonary edema - Acute lung injury - ARDS
II.g - Negative pressure pulmonary edema (NPPE) IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma IV.f IV - Airway involvement
IV.f - Severe or catastrophic bronchospasm or asthma attack (can be fatal) VIII.a VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.a - Angioedema (may cause UAO, asphyxia and death) VIII.f VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia X.f X - Systemic/Distant conditions, syndromes and reactions
X.f - Anaphylaxis-Anaphylactoid reaction (can be fatal) XI.a XI - Miscellaneous
XI.a - Cyanosis, a low SpO2 and normal measured PaO2 XI.r XI - Miscellaneous
XI.r - Death following exposure or poisoning XII.l XII - Cardiovascular involvement / toxicity
XII.l - Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP) XII.m XII - Cardiovascular involvement / toxicity
XII.m - Cardiac- cardiorespiratory/pulmonary arrest XIV.a XIV - Hemoglobinopathies - Abnormal hemoglobin states (acquired)
XIV.a - Methemoglobinemia
II.a - Pulmonary edema, noncardiogenic (NCPE) II.b II - Pulmonary edema - Acute lung injury - ARDS
II.b - ARDS - Acute lung injury II.g II - Pulmonary edema - Acute lung injury - ARDS
II.g - Negative pressure pulmonary edema (NPPE) IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma IV.f IV - Airway involvement
IV.f - Severe or catastrophic bronchospasm or asthma attack (can be fatal) VIII.a VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.a - Angioedema (may cause UAO, asphyxia and death) VIII.f VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia X.f X - Systemic/Distant conditions, syndromes and reactions
X.f - Anaphylaxis-Anaphylactoid reaction (can be fatal) XI.a XI - Miscellaneous
XI.a - Cyanosis, a low SpO2 and normal measured PaO2 XI.r XI - Miscellaneous
XI.r - Death following exposure or poisoning XII.l XII - Cardiovascular involvement / toxicity
XII.l - Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP) XII.m XII - Cardiovascular involvement / toxicity
XII.m - Cardiac- cardiorespiratory/pulmonary arrest XIV.a XIV - Hemoglobinopathies - Abnormal hemoglobin states (acquired)
XIV.a - Methemoglobinemia
1
Sildenafil
III.a
III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.a - Alveolar hemorrhage (AH), diffuse AH (DAH) III.c III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.c - Hemoptysis IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion (uni- or bilateral) (can accompany DI-LDs) VIII.f VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia XII.m XII - Cardiovascular involvement / toxicity
XII.m - Cardiac- cardiorespiratory/pulmonary arrest
III.a - Alveolar hemorrhage (AH), diffuse AH (DAH) III.c III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.c - Hemoptysis IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion (uni- or bilateral) (can accompany DI-LDs) VIII.f VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
VIII.f - Central airway instability - Tracheomalacia XII.m XII - Cardiovascular involvement / toxicity
XII.m - Cardiac- cardiorespiratory/pulmonary arrest
1